You are using an outdated browser. Please upgrade your browser to improve your experience.
Metric Pro

The goal of this study is to describe the natural history of Medullary Thyroid Cancer (MTC) via the utilization of a novel multi-institutional registry in order to understand the pathway to progressive disease requiring drug therapy, integrating for the first time the patient perspective in order to identify patient reported outcome measures that could inform decision-making around current treatment and that could be included in clinical trial design for the development of emerging drug therapies for advanced MTC

The goal of this study is to describe the natural history of Medullary Thyroid Cancer (MTC) via the utilization of a novel multi-institutional registry in order to understand the pathway to progressive disease requiring drug therapy, integrating for the first time the patient perspective in order to identify patient reported outcome measures that could inform decision-making around current treatment and that could be included in clinical trial design for the development of emerging drug therapies for advanced MTC

Metric Pro

by e-Health Technology
Metric Pro
Metric Pro
Metric Pro

What is it about?

The goal of this study is to describe the natural history of Medullary Thyroid Cancer (MTC) via the utilization of a novel multi-institutional registry in order to understand the pathway to progressive disease requiring drug therapy, integrating for the first time the patient perspective in order to identify patient reported outcome measures that could inform decision-making around current treatment and that could be included in clinical trial design for the development of emerging drug therapies for advanced MTC.

Metric Pro

App Details

Version
1.0.12
Rating
(1)
Size
50Mb
Genre
Health & Fitness Medical
Last updated
February 28, 2024
Release date
March 17, 2020
More info

App Screenshots

Metric Pro screenshot-0
Metric Pro screenshot-1
Metric Pro screenshot-2
Metric Pro screenshot-3

App Store Description

The goal of this study is to describe the natural history of Medullary Thyroid Cancer (MTC) via the utilization of a novel multi-institutional registry in order to understand the pathway to progressive disease requiring drug therapy, integrating for the first time the patient perspective in order to identify patient reported outcome measures that could inform decision-making around current treatment and that could be included in clinical trial design for the development of emerging drug therapies for advanced MTC.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.